Mortality risk according to 3 ng/mL suPAR intervals in patients aged ≤70 years or >70 years
| 30 days | 90 days | ||||
|---|---|---|---|---|---|
| suPAR (ng/mL) | % in interval (n) | Mortality % (n) | 95% CI* | Mortality % (n) | 95% CI* |
| ≤70 years | |||||
| All | 100.0 (2652) | 1.5 (41) | 1.1 to 2.0 | 2.9 (77) | 2.2 to 3.6 |
| 0–3 | 64.3 (1705) | 0.3 (5) | 0.1 to 0.7 | 0.8 (14) | 0.5 to 1.4 |
| 3–6 | 28.1 (744) | 1.6 (12) | 0.8 to 2.8 | 3.6 (27) | 2.4 to 5.2 |
| 6–9 | 4.8 (127) | 7.1 (9) | 3.3 to 13.0 | 11.8 (15) | 6.8 to 18.7 |
| >9 | 2.9 (76) | 19.7 (15) | 11.5 to 30.5 | 27.6 (21) | 18.0 to 39.1 |
| >70 years | |||||
| All | 100.0 (1691) | 10.8 (183) | 9.3 to 12.3 | 18.3 (309) | 16.4 to 20.1 |
| 0–3 | 20.0 (339) | 2.7 (9) | 1.2 to 5.0 | 3.5 (12) | 1.8 to 6.1 |
| 3–6 | 54.0 (913) | 7.1 (65) | 5.5 to 9.0 | 13.7 (125) | 11.5 to 16.1 |
| 6–9 | 17.3 (293) | 19.8 (58) | 15.4 to 24.8 | 32.8 (96) | 27.4 to 38.5 |
| >9 | 8.6 (146) | 34.9 (51) | 27.2 to 43.3 | 52.1 (76) | 43.6 to 60.4 |
*CIs were calculated using the Wald method.
suPAR, soluble urokinase plasminogen activator receptor.